# Andrea Angioi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andrea-angioi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,163 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 14 |
| i10-index | 17 |
| Last Known Institution | Azienda Ospedaliera G. Brotzu |
| OpenAlex ID | https://openalex.org/A5084214896 |
| ORCID iD | 0000-0001-8311-5409 |
| Works | 76 |

## Researcher papers

- [The MEST score provides earlier risk prediction in lgA nephropathy](https://scholariq.org/papers/the-mest-score-provides-earlier-risk-prediction-in-lga-nephropathy/)
- [Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update](https://scholariq.org/papers/is-there-long-term-value-of-pathology-scoring-in-immunoglobulin-a-nephropathy-a/)
- [Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy](https://scholariq.org/papers/development-and-testing-of-an-artificial-intelligence-tool-for-predicting-end/)
- [Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study](https://scholariq.org/papers/clinicopathologic-predictors-of-renal-outcomes-in-light-chain-cast-nephropathy-a/)
- [Diagnosis of complement alternative pathway disorders](https://scholariq.org/papers/diagnosis-of-complement-alternative-pathway-disorders/)
- [Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy](https://scholariq.org/papers/application-of-the-international-iga-nephropathy-prediction-tool-one-or-two/)
- [Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: results of a proteomic analysis](https://scholariq.org/papers/complement-activation-in-pauci-immune-necrotizing-and-crescentic/)
- [Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool](https://scholariq.org/papers/improving-treatment-decisions-using-personalized-risk-assessment-from-the/)
- [Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up](https://scholariq.org/papers/metformin-associated-lactic-acidosis-a-case-series-of-28-patients-treated-with/)
- [Bortezomib-induced acute interstitial nephritis](https://scholariq.org/papers/bortezomib-induced-acute-interstitial-nephritis/)
- [Management of immune-mediated glomerular diseases in the elderly](https://scholariq.org/papers/management-of-immune-mediated-glomerular-diseases-in-the-elderly/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)

## Researcher university

- [Azienda Ospedaliera G. Brotzu](https://scholariq.org/institutions/azienda-ospedaliera-g-brotzu/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.